Policy and advocacy

Regulations: Monitor, analyse, understand and foresee evolving trends, standards and policies in marketing authorisation, Pricing and Reimbursement, Health Economics Outcomes Research, Health Technology Assessment, access, patient engagement, and advocacy.
Policy impact: Quantify impact and risks associated with policies and regulations for industry and for product portfolio and company business activities.
Stakeholders: Map important stakeholders, in academia, payers, Health Technology Assessment (HTA) bodies, providers, patient advocacy groups, Governments, understand and foresee their priorities, thinking, and market needs.
Market: Monitor, understand and predict and market size, structure, prevailing health and other technological trends, demand drivers and critical factors for business success.
Disease: Understand therapy market dynamics, therapeutic alternatives, management pathways, unmet medical and economic needs.

Regulations: Pricing and Reimbursement, payer, HTA, market access landscape assessment, intelligence collection, trend analysis and insights, through desktop research, pricing stakeholder surveys, advisory boards, delphi panels and workshops.
Policy impact: Policy and regulation research & analysis, modelling, forecasting, impact analysis, risk analysis and mitigation, through workshops & advisory boards.
Stakeholders: Stakeholder mapping and segmentation studies, intelligence and insights development, analysis of needs and wants, through desktop research and reviews, surveys, advisory boards, and workshops;
Market: Market assessment, intelligence collection, trend analysis and insights, forecasting through desktop research, stakeholder surveys, advisory boards.
Disease: Rapid, targeted or systematic reviews of disease, market, Medical technology, guideline and patient management through desktop research, surveys, advisory boards and workshops.

Alignment: Coordinate with other business functions; Review and provide input into the development of the target product profile and the regulatory, medical technology, market access, evidence generation and brand plans.
Capacities: Assess internal organisational capacities, experience, gaps, and priorities at global, regional and national level and plan to cover any weakness and gaps.
Engagement: Engage with relevant stakeholders in pricing, reimbursement, health technology assessment, payer, governmental agencies, academia, professional associations, committees, and patient advocacy groups.

Alignment: Provide cross functional alignment through workshops and facilitation; Review and provide input into the development of the target product profile and the regulatory, medical, market access, evidence generation and brand plans.
Capacities: Review, undertake benchmarking and assess internal organisational capacities, to provide advice, training and support to cover gaps at different levels and functions.
Engagement: Identify and select stakeholders in relevant agencies and organisations, develop networks and engage effectively through scientific and advocacy events, research, and other relevant activities aiming to establish trusted relationships.

Strategy: Assess market dynamics, portfolio life cycle strategic plan and business priorities; Identifying policy priorities and objectives to overcome key barriers; Generate policies that shape favourable access and funding environments, and uptake of products.
Operations: Develop operational plan for managing and implementing policy; develop evidence generation, advocacy, and communication pan at supranational and national level .

Strategy: Analytics, modelling and forecasting; Develop strategies and policy positions that address access barriers, support patient choice and ensure a sustainable pharmaceutical industry; Through research, advisory boards and technology committees.
Operations: Review, benchmarking and assess internal organisational capacities and provide advice, training and support; digital health business strategy; re-organisation plans; workshops and cross function alignment facilitation.

Build Value Evidence: Build evidence to demonstrate gaps and weakness, Pricing & Reimbursement, HTA, Market Access models and regulations; Generate evidence to support recommendations; Quantity potential value.
Communicate Value: Build strategy and tools to communicate policy recommendations value to stakeholders in convincingly meaningful, relevant, and customised manner to attain from them positive perceptions and decisions.

Build Value Evidence: Policy and regulation research & analysis, modelling, forecasting, impact analysis, risk analysis and mitigation, through through desktop research and reviews, surveys, advisory boards, and workshops.
Communicate Value: Identify and select targets in relevant agencies and organisations; Develop engagement and communication plans; Engagement plans; Develop relevant networks and engage effectively through scientific and advocacy events and campaigns.

Infrastructure: Train, guide and support staff in negotiations with stakeholders and customer engagement; Develop corporate infrastructure and skills; Integrate access to functional domains.Facilitate cross-functional collaboration.
Impact Policy: Engage with stakeholders and communicate effectively to shape regulatory and policy environment with thought leadership work undertaken together with external partners to make it positive for company interests .

Infrastructure: Undertake bespoke training on soft and technical skills development; Give advice on organisational issues and capacity development; Organise internal brainstorming and alignment workshops; Facilitate cross-functional collaboration.
Impact Policy: Support client engagement with stakeholders with tailor made advisory work, presentations, workshops, publications, and scientific, communication and advocacy events; identify and educating advocacy groups to inform policymakers; support communications and media relations activities.